西部证券股份有限公司 关于湖南华曙高科技股份有限公司 首次公开发行部分限售股解禁上市流通的核查意见 西部证券股份有限公司（以下简称"西部证券"或"保荐人"）作为湖南华曙高 科技股份有限公司（（以下简称"华曙高科"、"公司"）首次公开发行股票并在科创 板上市的保荐人，根据《中华人民共和国公司法》《中华人民共和国证券法》《证 券发行上市保荐业务管理办法》《上海证券交易所科创板股票上市规则》以及《科 创板上市公司持续监管办法（试行）》等有关规定，对华曙高科首次公开发行部 分限售股解禁上市流通的事项进行了审慎核查，并出具本核查意见。核查情况如 下： 一、 本次上市流通的限售股类型 根据中国证券监督管理委员会于 2023 年 2 月 27 日出具的《关于同意湖南华 曙高科技股份有限公司首次公开发行股票注册的批复》（证监许可〔2023〕421 号）， 公司公开发行面值为 1 元的人民币普通股 41,432,253 股，并于 2023 年 4 月 17 日 在上海证券交易所科创板挂牌上市。公司首次公开发行前总股本为 372,736,547 股，首次公开发行后总股本为 414,168,800 股，其中有限售条件流通股 379 ...

证券代码：688433 证券简称：华曙高科 湖南华曙高科技股份有限公司 投资者关系活动记录表 特定对象调研 □分析师会议 □媒体采访 □业绩说明会 投资者关系 活动类别 □新闻发布会 □路演活动 □现场参观 □其他 时间 2023年9月19日—9月 21日 地点 湖南华曙高科技股份有限公司会议室 董事、副总经理、董事会秘书 刘一展 公司接待人员 证券事务代表 易钧栎 广发基金、德邦证券、海富通基金、华创证券、 中邮基金、建信理财、尚善资产、中天国富证 9月19日 券、穿石投资、国泰君安资管、西南证券、湖南 甲骨文私募、海南劲恒私募、长沙皓熙投资 参会单位 中航证券、鲁信创投、汪洋浩博、四叶草、太平 9月20日 洋证券、信达证券 9月21日 中信建投、交银基金、大家资产、建信理财 1、Flight技术是什么？具备哪些优势？ 答： Flight 技术是公司自主研发的一种采用光纤激光器作为能 ...

Environmental Compliance - The company obtained an environmental discharge permit from the environmental protection authority, with major pollutants including waste gas, wastewater, and solid waste [7]. - No exceedance of discharge limits for waste gas, wastewater, and solid waste was reported during the reporting period [7]. - The company has implemented low-carbon energy-saving and resource recycling measures to reduce indirect greenhouse gas emissions [13]. - The company utilizes advanced additive manufacturing technology, which is a new environmentally friendly manufacturing method with high material utilization rates [13]. - The company is not classified as a major environmental polluter and does not fall under the national key monitoring enterprises for wastewater, waste gas, and hazardous waste [11]. - The company has conducted environmental monitoring of waste gas, wastewater, and noise, with data subject to supervision by the environmental protection authority [10]. Shareholder Commitments - The company has committed to shareholding restrictions for various stakeholders, with commitment periods ranging from 12 to 36 months from the date of stock listing [14]. - The company committed to a 36-month lock-up period for shares held prior to the IPO, starting from the date of listing [17]. - Shareholders are prohibited from transferring or managing their shares during the lock-up period, with automatic extensions if stock prices fall below the IPO price [17]. - After the lock-up period, shareholders can only transfer up to 25% of their shares annually while adhering to legal regulations [22]. - The company has established measures to ensure compliance with commitments, including compensation for losses caused by non-compliance [22]. - Shareholders must disclose any plans for share reduction and ensure stable company operations [17]. - The company will not repurchase shares held prior to the IPO during the lock-up period [17]. - If the stock price falls below the IPO price for 20 consecutive trading days, the lock-up period will be extended by at least 6 months [22]. - Shareholders are required to report any changes in their shareholdings promptly [22]. - The commitments are in line with the regulations of the Shanghai Stock Exchange and relevant securities laws [22]. - The company emphasizes strict adherence to the commitments to maintain investor confidence and market stability [22]. - The company will not transfer or delegate the management of its pre-IPO shares within 12 months of the stock listing [24]. - The company commits to not transferring more than 25% of its pre-IPO shares annually for four years after the lock-up period ends [48]. Financial Performance - Total operating revenue for the first half of 2023 reached ¥240,879,846.35, an increase of 36.5% compared to ¥176,204,813.26 in the same period of 2022 [115]. - Total operating costs for the first half of 2023 were ¥195,291,002.62, up from ¥144,347,398.55 in the first half of 2022, reflecting a growth of 35.4% [115]. - Research and development expenses increased to ¥38,766,955.35 in the first half of 2023, compared to ¥25,097,518.54 in the same period of 2022, marking a rise of 54.6% [115]. - Net profit for the first half of 2023 was ¥42,506,308.36, compared to ¥31,620,413.89 in the previous year, indicating a year-over-year increase of about 34.5% [117]. - The basic and diluted earnings per share for the first half of 2023 were both ¥0.1100, up from ¥0.0848 in the same period of 2022, reflecting an increase of approximately 30.5% [118]. - The company's operating profit for the first half of 2023 was ¥46,240,124.73, compared to ¥34,691,995.45 in the previous year, marking an increase of around 33.4% [117]. - The total profit for the first half of 2023 was ¥46,406,222.92, compared to ¥34,883,580.94 in the previous year, indicating a growth of about 33.5% [117]. - The company's total assets as of June 30, 2023, amounted to ¥2,179,348,734.96, significantly higher than ¥1,139,550,236.52 at the end of 2022 [112]. - The total liabilities decreased to ¥342,892,597.24 from ¥374,298,307.04, indicating a reduction of approximately 8.4% [112]. - The equity attributable to shareholders increased to ¥1,836,456,137.72, up from ¥765,251,929.48, representing a growth of 140.0% [112]. - Cash and cash equivalents rose to ¥1,136,975,623.90, compared to ¥307,899,186.19 at the end of 2022, showing an increase of 269.5% [112]. Investment and Capital Management - The company plans to invest a total of CNY 329,405,000 in the additive manufacturing equipment expansion project, with a cumulative investment of CNY 3,961,217.98 as of the reporting period, representing 1.20% of the planned investment [46]. - The R&D headquarters and industrial application center project has a total planned investment of CNY 283,854,800, with no cumulative investment reported as of the reporting period [46]. - The company is also investing CNY 50,696,300 in the establishment of the Additive Manufacturing Technology Innovation (Shanghai) Research Institute, with no cumulative investment reported as of the reporting period [46]. - The company has raised excess funds amounting to CNY 359,378,285.36 from the IPO, with a cumulative investment of CNY 10,849,912.87, representing 3.02% of the planned investment [46]. - The company will accept supervision from regulatory authorities regarding share repurchase plans and will bear legal responsibilities for non-compliance [29]. - The company will ensure that any amendments to the share repurchase plan are submitted for shareholder approval [25]. - The company has established a fundraising management system to ensure the legal and compliant use of raised funds, safeguarding investor interests [59]. - The company will not engage in unrelated investments or consumption activities that could harm its interests [59]. - The company will actively manage and supervise the use of raised funds to prevent risks associated with their usage [59]. Regulatory Compliance and Governance - The company has committed to ensuring that its prospectus for the initial public offering (IPO) on the Sci-Tech Innovation Board is free from false records, misleading statements, or significant omissions, and will bear legal responsibility for its accuracy and completeness [33]. - If the prospectus contains any false records or significant omissions that lead to investor losses, the company will compensate investors as per legal requirements [34]. - The company will publicly disclose reasons for any failure to fulfill commitments and apologize to shareholders if such events occur [67]. - The company has agreed to compensate investors for any losses incurred due to non-fulfillment of commitments [68]. - The company will not increase salaries or allowances for its directors and senior management until the negative impacts of any unfulfilled commitments are fully resolved [68]. - The company has no significant doubts regarding its ability to continue as a going concern for the next 12 months [177]. - The financial statements comply with the requirements of the accounting standards, accurately reflecting the company's financial position [178]. - The company has implemented specific accounting policies for financial instruments, fixed asset depreciation, and revenue recognition [177]. Market Position and Strategy - The company plans to enhance its market expansion capabilities and brand influence through increased R&D investment and product innovation [59]. - The company has expanded its market presence, with ongoing investments in new product development and technology [170]. - The company has committed to avoiding any substantial competition with its controlled subsidiaries and will not engage in similar business activities [35]. - The company will ensure that any necessary related party transactions are conducted fairly and transparently, adhering to market prices and legal regulations [38]. Financial Instruments and Valuation - The company measures financial assets at amortized cost and recognizes gains or losses in profit or loss upon derecognition, reclassification, or impairment [187]. - Financial liabilities are measured at fair value, with changes recognized in profit or loss unless they are part of a hedging relationship [190]. - The company uses valuation techniques supported by sufficient data to determine the fair value of financial assets and liabilities, categorized into three levels [190]. - The company recognizes goodwill when the acquisition cost exceeds the fair value of identifiable net assets acquired [194]. - The company terminates recognition of financial assets when it transfers almost all risks and rewards of ownership [189]. - The company measures expected credit losses for receivables and contract assets using a simplified approach based on historical credit loss experience [191]. - Foreign currency transactions are translated at the exchange rate on the transaction date, with differences recognized in profit or loss [196]. - The company confirms financial assets or liabilities upon becoming a party to a financial instrument contract, initially measuring them at fair value [198]. - The company recognizes revenue from joint ventures based on its share of the output generated [195]. - The company applies a simplified method for measuring expected credit losses for aging receivables [192].

证券代码：688433 证券简称：华曙高科 公告编号：2023-010 湖南华曙高科技股份有限公司 关于使用募集资金置换预先投入募投项目和已支付发 行费用的自筹资金的公告 | 序号 | 项目名称 | 总投资 | 募集资金投资金额 | | --- | --- | --- | --- | | 1 | 增材制造设备扩产项目 | 32,940.50 | 32,940.50 | | 2 | 研发总部及产业化应用中心项目 | 28,385.48 | 28,385.48 | | 3 | 增材制造技术创新（上海）研究院建设项目 | 5,069.63 | 5,069.63 | | | 合计 | 66,395.61 | 66,395.61 | 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 湖南华曙高科技股份有限公司（以下简称"公司"或"华曙高科"）于2023 年8月28日召开第一届董事会第十二次会议和第一届监事会第八次会议，审议通过 了《关于使用募集资金置换预先投入募投项目和已支付发行费用的自筹资金的议 案》，同意公司使用募集资金置换预先投 ...

湖南华曙高科技股份有限公司独立董事 独立董事：谭援强、张珺、吴宏、李琳 关于第一届董事会第十二次会议相关事项的独立意见 湖南华曙高科技股份有限公司（以下简称"公司"）第一届董事会第十二 次会议于2023年8月28日召开。根据《中华人民共和国公司法》《中华人民共和国 证券法》《上海证券交易所科创板股票上市规则》等法律、法规和规范性文件以 及《湖南华曙高科技股份有限公司章程》（以下简称"《公司章程》"）、《湖南 华曙高科技股份有限公司独立董事工作制度》等相关规定，作为公司的独立董事， 本着认真、负责的态度，基于独立、审慎、客观的原则，我们认真审阅了本次会 议的相关资料，现就会议审议相关事项发表独立意见如下： 二、关于2023年半年度募集资金存放与使用情况的专项报告的议案 我们认为，公司严格按照《上市公司监管指引第2号——上市公司募集资金 管理和使用的监管要求》《上海证券交易所科创板上市公司自律监管指引第1号 ——规范运作》及《湖南华曙高科技股份有限公司募集资金管理制度》等有关规 定，管理和使用募集资金，公司2023年半年度募集资金存放与使用情况与《2023 年半年度募集资金存放与使用情况的专项报告》内容相符，不存 ...

关于2023年半年度募集资金存放与使用情况的专项报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 根据中国证券监督管理委员会《上市公司监管指引第2号——上市公司募集资金 管理和使用的监管要求》、《上海证券交易所科创板上市公司自律监管指引第1号— —规范运作》的相关规定，湖南华曙高科技股份有限公司（以下简称"公司"）就2023 年半年度募集资金存放与实际使用情况作如下专项报告： 一、募集资金基本情况 （一）实际募集资金金额及到账情况 根据中国证券监督管理委员会于2023年2月27日出具的《关于同意湖南华曙高科 技股份有限公司首次公开发行股票注册的批复》（证监许可〔2023〕421号），公司 公开发行面值为1元的人民币普通股4,143.2253万股，发行价格为26.66元/股，募集资 金总额为1,104,583,864.98元，扣除发行费用81,249,479.62元（不含增值税，其中使用 自有资金已支付的发行费用1,997,249.43元及尚未支付的发行费用69,811.32元)后，实 际募集资金净额为1,023,334 ...

经审议，监事会认为：公司2023年半年度报告编制和审议程序符合相关法律 法规及《公司章程》等相关规定，公允地反映了公司2023年半年度的财务状况和 经营成果；在编制过程中，未发现公司参与半年度报告编制和审议的人员有违反 保密规定的行为。公司2023年半年度报告所披露的信息真实、准确、完整，所载 资料不存在任何虚假记载、误导性陈述或重大遗漏。 证券代码：688433 证券简称：华曙高科 公告编号：2023-012 湖南华曙高科技股份有限公司 第一届监事会第八次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开情况 湖南华曙高科技股份有限公司（以下简称"公司"）第一届监事会第八次会议 于2023年8月28日以现场结合通讯方式召开，会议通知已于2023年8月18日以通讯 方式送达至全体监事。本次应出席会议监事3名，实际出席会议监事3名，会议由 公司监事会主席李昕彦女士召集并主持。本次会议的召集、召开符合法律、行政 法规、部门规章和《湖南华曙高科技股份有限公司章程》（以下简称《公司章程》 " "） 的 ...

一、以自筹资金预先投入募投项目及支付发行费用的鉴证报告…第 1—2 页 二、以自筹资金预先投入募投项目及支付发行费用的专项说明…第 3—4 页 以自筹资金预先投入募投项目及支付发行费用的 鉴证报告 天健审〔2023〕2-401 号 湖南华曙高科技股份有限公司全体股东： 目 录 三、附件…………………………………………………………… 第 5-8 页 （一）本所营业执照复印件…………………………………… 第 5 页 （二）本所执业证书复印件…………………………………… 第 6 页 （三）本所签字注册会计师执业证书复印件…………… 第 7—8 页 关于湖南华曙高科技股份有限公司 我们鉴证了后附的湖南华曙高科技股份有限公司（以下简称华曙高科公司） 管理层编制的《以自筹资金预先投入募投项目及支付发行费用的专项说明》。 一、对报告使用者和使用目的的限定 本鉴证报告仅供华曙高科公司为以募集资金置换预先投入募投项目及支付 发行费用的自筹资金之目的使用，不得用作任何其他目的。 二、管理层的责任 华曙高科公司管理层的责任是提供真实、合法、完整的相关资料，按照《上 市公司监管指引第 2 号——上市公司募集资金管理和使用的监管要求（ ...

西部证券股份有限公司（以下简称"西部证券"、"保荐人"）作为湖南 华曙高科技股份有限公司（以下简称"公司"、"华曙高科"）首次公开发行 股票并上市的保荐人，根据《证券发行上市保荐业务管理办法》《上市公司监 管指引第 2 号——上市公司募集资金管理和使用的监管要求（2022 年修订）》 《上海证券交易所科创板上市公司自律监管指引第 1 号——规范运作》《上海 证券交易所科创板股票上市规则（2020 年 12 月修订）》等有关规定，对华曙 高科使用募集资金置换预先投入的自有资金的事项进行了核查，具体情况如 下： 西部证券股份有限公司 关于湖南华曙高科技股份有限公司 使用募集资金置换预先投入募投项目和已支付发行 费用的自筹资金的核查意见 单位：人民币万元 | | 项目名称 | 总投资 | 募集资金投资金额 | | --- | --- | --- | --- | | 序号 | | | | 一、募集资金基本情况 根据中国证券监督管理委员会于2023年2月27日出具的《关于同意湖南华曙 高科技股份有限公司首次公开发行股票注册的批复》（证监许可〔2023〕421号）， 公司获准公开发行面值为1.00元的人民币普通股4,14 ...

证券代码：688433 证券简称：华曙高科 公告编号：2023-013 湖南华曙高科技股份有限公司 关于参加2023年半年度高端装备行业 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 投资者可于2023年9月6日(星期三)16:00前通过邮件、电话、传真等形式将 需要了解和关注的问题提前提供给公司。公司将以适当方式对投资者普遍关注的 问题进行回答。 湖南华曙高科技股份有限公司（以下简称"公司"）于2023年8月29日发布公 司2023年半年度报告，为便于广大投资者更全面深入地了解公司2023年半年度经 营成果、财务状况、发展理念，公司参与了由上交所主办的2023年半年度高端装 备行业集体业绩说明会，此次活动将采用视频和网络文字互动的方式举行，投资 者可登录上海证券交易所上证路演中心（http://roadshow.sseinfo.com/）参与线上互 动交流。 集体业绩说明会的公告 三、参加人员 董事、总经理：侯培林先生 一、说明会类型 本次业绩说明会以视频和网络文字互动形式召开，公司将针对2023年半年 ...